Drug Trial Radar · NCT03155997
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
Last checked: Nov 20, 2026Latest source record: Apr 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
5,637
Actual
Start
Jul 12, 2017
Primary completion
Mar 16, 2020
Study completion May 2029
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- Collaborators
- NSABP Foundation Inc
- First posted
- May 16, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of the study drug abemaciclib in participants with high risk, node positive, early stage, hormone receptor positive (HR+), human epidermal receptor 2 negative (HER2-), breast cancer.
Conditions
- Breast Cancer
Interventions
AbemaciclibDrug
Administered orally.
Standard Adjuvant Endocrine TherapyDrug
Administered according to label instructions.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Invasive Disease Free Survival (IDFS)Time frame: Baseline to Recurrence or Death from Any Cause (Up to 32 Months)
Locations
619 sites in 38 countries. Site status is shown where the registry gives one.
University of Alabama Birmingham
Birmingham, Alabama
Providence Alaska Medical Center
Anchorage, Alaska
Banner MD Anderson Cancer Center
Gilbert, Arizona
Arizona Oncology Associates, P.C. - HOPE
Goodyear, Arizona
St. Joseph's Hospital and Medical Center
Phoenix, Arizona
Mayo Clinic Hospital
Phoenix, Arizona
The University of Arizona Cancer Center
Tucson, Arizona
Yuma Regional Cancer Center
Yuma, Arizona
St. Bernards Medical Center
Jonesboro, Arkansas
Highlands Oncology Group
Springdale, Arkansas
Beverly Hills Cancer Center
Beverly Hills, California
Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center
Burbank, California
City of Hope National Medical Center
Duarte, California
California Cancer Associates Research and Excellence
Fresno, California
Kaiser Permanente
Harbor City, California
Loma Linda University School of Medicine
Loma Linda, California
Cedars-Sinai Medical Center
Los Angeles, California
Pacific Cancer Care
Monterey, California
St. Joseph Hospital
Orange, California
University of California Davis (UC Davis) Comprehensive Cancer Center
Sacramento, California
UCSF Medical Center at Mission Bay
San Francisco, California
California Cancer Associates in Research and Excellence
San Marcos, California
Dignity Health Dominican Oncology and Hematology
Santa Cruz, California
Kaiser Permanente
Vallejo, California
USO-Rocky Mountain Cancer Center
Boulder, Colorado
USO-Rocky Mountain Cancer Center
Thornton, Colorado
Yale-New Haven Hospital
New Haven, Connecticut
Florida Cancer Specialists - South
Fort Myers, Florida
University of Florida College of Medicine
Gainesville, Florida
Millennium Oncology - Hollywood
Hollywood, Florida
Mayo Clinic in Florida
Jacksonville, Florida
Cancer Specialists of North Florida
Jacksonville, Florida
Florida Cancer Specialists - North
Lecanto, Florida
Ocala Oncology, P.A.
Ocala, Florida
Tallahassee Memorial Cancer Center
Tallahassee, Florida
Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center
Tampa, Florida
University Cancer & Blood Center, LLC
Athens, Georgia
Northside Hospital
Atlanta, Georgia
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital
Marietta, Georgia
Summit Cancer Care DBA Candler Medical Oncology Practice
Savannah, Georgia
Showing 40 of 619 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.